Balood M - Search Results

1

Increased autotaxin activity in multiple sclerosis.

Zahednasab H, Balood M, Harirchian MH, Mesbah-Namin SA, Rahimian N, Siroos B. Zahednasab H, et al. Among authors: balood m. J Neuroimmunol. 2014 Aug 15;273(1-2):120-3. doi: 10.1016/j.jneuroim.2014.06.006. Epub 2014 Jun 19. J Neuroimmunol. 2014. PMID: 24984830

2

Secretory phospholipase A2 activity in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.

Siroos B, Balood M, Zahednasab H, Mesbah-Namin SA, Pourgholy F, Harirchian MH. Siroos B, et al. Among authors: balood m. J Neuroimmunol. 2013 Sep 15;262(1-2):125-7. doi: 10.1016/j.jneuroim.2013.06.009. Epub 2013 Jul 13. J Neuroimmunol. 2013. PMID: 23859159

3

Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.

Balood M, Zahednasab H, Siroos B, Mesbah-Namin SA, Torbati S, Harirchian MH. Balood M, et al. Hum Immunol. 2014 May;75(5):411-3. doi: 10.1016/j.humimm.2014.02.021. Epub 2014 Feb 12. Hum Immunol. 2014. PMID: 24530753

4

Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.

Emami Aleagha MS, Siroos B, Ahmadi M, Balood M, Palangi A, Haghighi AN, Harirchian MH. Emami Aleagha MS, et al. Among authors: balood m. J Neuroimmunol. 2015 Apr 15;281:5-8. doi: 10.1016/j.jneuroim.2015.02.004. Epub 2015 Feb 21. J Neuroimmunol. 2015. PMID: 25867461

5

C/EBP homologous protein investigation in the serum and cerebro-spinal fluid of relapsing-remitting multiple sclerosis patients.

Karami M, Aleagha MSE, Seidkhani-Nahal A, Bakhtiyari S, Noori-Zadeh A, Harirchian MH, Siroos B, Balood M, Khosravi A. Karami M, et al. Among authors: balood m. J Clin Neurosci. 2019 Jan;59:51-54. doi: 10.1016/j.jocn.2018.11.008. Epub 2018 Nov 13. J Clin Neurosci. 2019. PMID: 30446370 Free article.

6

Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.

Zahednasab H, Mesbah-Namin SA, Sahraian MA, Balood M, Doosti R. Zahednasab H, et al. Among authors: balood m. Neurosci Lett. 2013 Jun 17;545:46-9. doi: 10.1016/j.neulet.2013.04.014. Epub 2013 Apr 22. Neurosci Lett. 2013. PMID: 23618653

7

Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.

Balood M, Mesbah-Namin SA, Sanati MH, Zahednasab H, Sahraian MA, Ataei M. Balood M, et al. Mol Biol Rep. 2014 Feb;41(2):613-6. doi: 10.1007/s11033-013-2898-3. Epub 2013 Dec 25. Mol Biol Rep. 2014. PMID: 24368589

8

The role of miR-326 and miR-26a in MS disease activity.

Zahednasab H, Balood M. Zahednasab H, et al. Among authors: balood m. Gene. 2014 Sep 10;548(1):158. doi: 10.1016/j.gene.2014.07.014. Epub 2014 Jul 8. Gene. 2014. PMID: 25014135 No abstract available.

9

Soluble CD40 ligand derived from serum is not correlated with early MS.

Zahednasab H, Siroos B, Balood M, Aleagha MSE, Harirchian MH. Zahednasab H, et al. Among authors: balood m. Mult Scler Relat Disord. 2017 May;14:29-31. doi: 10.1016/j.msard.2016.11.004. Epub 2016 Nov 10. Mult Scler Relat Disord. 2017. PMID: 28619427

10

Comment on "matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis".

Zahednasab H, Balood M, Mesbah-Namin SA. Zahednasab H, et al. Among authors: balood m. Pediatr Neurol. 2013 Mar;48(3):255. doi: 10.1016/j.pediatrneurol.2012.12.002. Pediatr Neurol. 2013. PMID: 23419481 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page